Company Filing History:
6 out of 1,168 
3 out of 4,126 
1 out of 48 Years Active: 1998-2024
Title: The Innovative Contributions of Benjamin Geiger
Introduction
Benjamin Geiger is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of biomedical research, particularly in the area of T cell culture and proteasome inhibitors. With a total of 8 patents to his name, Geiger's work has the potential to impact therapeutic approaches in various diseases.
Latest Patents
Geiger's latest patents include innovative methods for culturing T cells. One of his notable inventions provides a method of culturing T cells in the presence of a T cell stimulator, exogenous CCL21, and exogenous ICAM1. This method enhances the culturing process of T cells, leading to improved cell cultures and isolated T cells. Another significant patent focuses on proteasome inhibitors, detailing a method for treating diseases where proteasome inhibition is beneficial. This method involves administering a compound that binds to a proteasome, with specific interactions that target cysteine residues in the proteasome's subunits, thereby offering a novel approach to treatment.
Career Highlights
Throughout his career, Benjamin Geiger has worked with esteemed organizations such as Yeda Research and Development Company and the Wisconsin Alumni Research Foundation. His research has contributed to advancements in understanding cellular mechanisms and therapeutic interventions.
Collaborations
Geiger has collaborated with notable colleagues, including Paul L. Kaufman and Zvi Kam. These partnerships have fostered a collaborative environment that enhances the innovation process in his research endeavors.
Conclusion
Benjamin Geiger's contributions to the field of biomedical research through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in medical treatments and therapies.